Atrovent Nebulising Solution 250mcg Ipratropium Bromide Vial

Atrovent Nebulising Solution 250mcg Ipratropium Bromide Vial

Atrovent Nebulising Solution is a highly effective bronchodilator used in the management of respiratory conditions such as chronic obstructive pulmonary disease (COPD) and asthma. Each vial contains 250 micrograms of the active ingredient, Ipratropium Bromide, which is specifically formulated for administration via a nebulizer, providing targeted relief and improved pulmonary function.

Product Specifications:
- Active Ingredient: Ipratropium Bromide
- Strength: 250 micrograms per vial
- Administration: Inhalation via nebulizer
- Packaging: Sterile, single-use vials
- Storage: Store in a cool, dry place away from direct sunlight

Common Applications:
- Management of chronic obstructive pulmonary disease (COPD)
- Relief of bronchospasm in patients with asthma
- Used as a maintenance treatment to prevent bronchospasm

User Groups:
- Patients with chronic respiratory diseases
- Individuals requiring maintenance therapy for obstructive airway conditions
- Suitable for adults and children over the age of 6 years when prescribed by a healthcare professional

Supplier Overview:
Boehringer Ingelheim is a global leader in the pharmaceutical industry, renowned for their commitment to research and development in respiratory medicine. With a legacy spanning over 130 years, they have established themselves as an authority in the field of pulmonary treatments. Their dedication to innovation and quality ensures that Atrovent Nebulising Solution is a product of the highest standard, reflecting their ongoing mission to provide advanced therapeutic options for patients with respiratory conditions.